Feature Article

Clinical Challenge: Addressing Psoriasis and Comorbid Obesity


Obesity is an independent risk factor for the development of psoriasis and is associated with a worse prognosis.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News


Depression in Patients With Psoriasis Is Seldom Screened For, Addressed

By February 22, 2019

Nearly nearly 50% of patients with psoriasis are not appropriately screened or treated for depression,


Methotrexate More Beneficial in Psoriasis Without Concomitant Arthritis

By February 21, 2019

The investigators sought to compare the efficacy and safety of methotrexate to treat psoriasis in patients with and without psoriatic arthritis.


T Cell Lymphopenia May Enhance Effectiveness of Fumaric Acid Ester Therapy for Psoriasis

By February 21, 2019

The main finding of this study was that the numbers of CD4+T, CD8+T, CD19+B, and CD56+NK cells were significantly reduced by treatment with FAEs.


Periodontal Health Should Be Monitored Closely in Patients With Psoriasis

By February 20, 2019

Patients with psoriasis reported significantly higher values for parameters that address periodontal inflammation.


Axial Disease More Common in Psoriatic Arthritis With Acute Skin Problems

By February 19, 2019

Patients with PsA and severe skin manifestations had earlier onset and axial disease.


Lexette Foam Now Available for Plaque Psoriasis

By February 15, 2019

Lexette (halobetasol propionate) foam 0.05% has been made available for patients 18 years of age and older for the topical treatment of plaque psoriasis.


Evidence Lacking for Persistence and Effectiveness of Systemic Psoriasis Therapies

By February 12, 2019

This systematic review was limited by literature that was lacking in survival analyses and inconsistent definitions of drug discontinuation across the literature.


Psoriasis Tx Linked to Drop in Noncalcified Coronary Plaque

February 11, 2019

Treatment of psoriasis with biologic therapy is associated with a reduction in noncalcified coronary plaque and improved plaque morphology.


Calcipotriol Plus Betamethasone Dipropionate Foam Offers Rapid, Effective Itch Relief in Psoriasis

By February 08, 2019

Compared with foam vehicle, calcipotriol plus betamethasone dipropionate foam offers more rapid and effective itch relief, with associated significant improvements in sleep and Dermatology Life Quality Index scores.


Psoriasis, Especially Severe Disease, Associated With Increased Risk for All-Cause Mortality

By February 08, 2019

Patients with psoriasis, particularly those with risk factors and severe disease, should receive appropriate screening and preventative intervention.

Sign up for Newsletters